Follow The Filings

KRT

Earnings company data as of 7:50 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS 0.44 — —
Rev — — —

Insider trades

Open-market buys and sales by KRT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All KRT insider trades
  • $30K bought by 1 insider
  • $599K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Marvin Cheng VP-Manufacturing, Secy
    Sale
    $291K 6,000 shares at $48.42 0.1% of stake
    Traded Sep 4–8 Filed Sep 8
    ↗
  2. Marvin Cheng VP-Manufacturing, Secy
    Sale
    $96K 2,000 shares at $47.75 <0.1% of stake
    Traded Sep 1 Filed Sep 2
    ↗
  3. Marvin Cheng VP-Manufacturing, Secy
    Sale
    $213K 4,500 shares at $47.33 60% of stake
    Traded Aug 20 Filed Aug 21
    ↗
  4. Jian Guo CFO
    Buy
    $30K 1,361 shares at $22.11 +4.6% to stake
    Traded Nov 12, 2025 Filed Nov 14, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 7 option exercises and 3 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
DEF 14A Filing Doc
8-K 4.01,9.01 Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
424B3 PROSPECTUS SUPPLEMENT Filing Doc
8-K 1.01,8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.